Camille Conger
Physician Assistant · Phoenix, AZNPI 1275174468
Payments from drug & device makers
Across 336 payments — averaging $30.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Sanofi$1K
- Actelion Pharmaceuticals US, Inc.$1K
- GSK$1K
- United Therapeutics Corporation$515
- Inspire Medical Systems, Inc.$388
- plus $3K from 32 others
What the payments were for
- Food & beverage$9,81496%
- Education$4174%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $2,571 |
| Sanofi | 39 | $1,255 |
| Actelion Pharmaceuticals US, Inc. | 21 | $1,227 |
| GSK | 60 | $1,117 |
| United Therapeutics Corporation | 11 | $515 |
| Inspire Medical Systems, Inc. | 9 | $388 |
| Boehringer Ingelheim | 14 | $375 |
| Regeneron Healthcare Solutions, Inc. | 9 | $272 |
| Grifols USA, LLC | 23 | $257 |
| Harmony Biosciences LLC | 9 | $251 |
| Electromed, Inc. | 24 | $231 |
| Novartis | 10 | $209 |
| Axsome Therapeutics, Inc. | 6 | $163 |
| Mylan Specialty L.p. | 6 | $133 |
| Pulmonx Corporation | 6 | $130 |
| Viatris Specialty LLC | 5 | $126 |
| Inogen, Inc. | 6 | $115 |
| Verona Pharma, Inc. | 3 | $96 |
| Genentech USA, Inc. | 3 | $80 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Amgen | 3 | $61 |
| Merck | 2 | $53 |
| Insmed, Inc. | 2 | $47 |
| Vapotherm Inc | 1 | $44 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $43 |
| Phadia US Inc. | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Pharming Healthcare, Inc. | 1 | $28 |
| Pfizer | 1 | $25 |
| ZOLL Respicardia, Inc. | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $23 |
| Philips North America LLC | 1 | $21 |
| Baxter Healthcare | 1 | $18 |
| Novo Nordisk | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,231 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 231 | $237,543 |
| XolairOmalizumab | 16 | $58,283 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 49 | $57,680 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 82 | $54,115 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $29,490 |
| Spiriva RespimatTiotropium Bromide | 33 | $26,601 |
| Advair HfaFluticasone Propion/Salmeterol | 26 | $19,321 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $12,990 |
| EliquisApixaban | 16 | $11,485 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 440 | $10,024 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $8,920 |
| Arnuity ElliptaFluticasone Furoate | 22 | $8,317 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 39 | $7,988 |
| Wixela InhubFluticasone Propion/Salmeterol | 32 | $7,798 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 25 | $2,057 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $1,117 | $312,964351 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $375 | $84,28182 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,571 | $38,40948 claims |
| PfizerEliquis | $25 | $11,48516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Phoenix
- Alyssa BoschenPhoenix$86K
- Katherine MinorPhoenix$76K
- Micah LasleyPhoenix$52K
- Thomas SirrinePhoenix$37K
- Karla HortonPhoenix$36K
- Larissa AnthonyPhoenix$32K
- Tana FrumentoPhoenix$25K
- Rosemary SrisukPhoenix$17K
- John DorseyPhoenix$17K
- Kendall SmithPhoenix$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.